Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Ibrutinib for B cell malignancies.

Novero A, Ravella PM, Chen Y, Dous G, Liu D.

Exp Hematol Oncol. 2014 Jan 28;3(1):4. doi: 10.1186/2162-3619-3-4.

2.

The nucleotide sugar UDP-glucose mobilizes long-term repopulating primitive hematopoietic cells.

Kook S, Cho J, Lee SB, Lee BC.

J Clin Invest. 2013 Aug;123(8):3420-35. doi: 10.1172/JCI64060. Epub 2013 Jul 25.

3.

Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor cell mobilization.

Smith VR, Popat U, Ciurea S, Nieto Y, Anderlini P, Rondon G, Alousi A, Qazilbash M, Kebriaei P, Khouri I, de Lima M, Champlin R, Hosing C.

Am J Hematol. 2013 Sep;88(9):754-7. doi: 10.1002/ajh.23499. Epub 2013 Jul 23.

4.

Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration.

Lucas D, Scheiermann C, Chow A, Kunisaki Y, Bruns I, Barrick C, Tessarollo L, Frenette PS.

Nat Med. 2013 Jun;19(6):695-703. doi: 10.1038/nm.3155. Epub 2013 May 5.

5.

Evaluating the effects of lenalidomide induction therapy on peripheral stem cells collection in patients undergoing autologous stem cell transplant for multiple myeloma.

Bhutani D, Zonder J, Valent J, Tageja N, Ayash L, Deol A, Al-Kadhimi Z, Abrams J, Lum L, Ratanatharathorn V, Uberti J, Abidi MH.

Support Care Cancer. 2013 Sep;21(9):2437-42. doi: 10.1007/s00520-013-1808-5. Epub 2013 Apr 17.

6.

New strategies for stem cell mobilization.

Lemoli RM.

Mediterr J Hematol Infect Dis. 2012;4(1):e2012066. doi: 10.4084/MJHID.2012.066. Epub 2012 Oct 3.

7.

Intrabone transplant of cord blood stem cells establishes a local engraftment store: a functional PET/FDG study.

Marini C, Podestà M, Massollo M, Capitanio S, Fiz F, Morbelli S, Brignone M, Bacigalupo A, Piana M, Frassoni F, Sambuceti G.

J Biomed Biotechnol. 2012;2012:767369. doi: 10.1155/2012/767369. Epub 2012 Oct 2.

8.

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.

Russell N, Douglas K, Ho AD, Mohty M, Carlson K, Ossenkoppele GJ, Milone G, Pareja MO, Shaheen D, Willemsen A, Whitaker N, Chabannon C.

Haematologica. 2013 Feb;98(2):172-8. doi: 10.3324/haematol.2012.071456. Epub 2012 Sep 14.

9.

Loss of CD26 protease activity in recipient mice during hematopoietic stem cell transplantation results in improved transplant efficiency.

Yoo E, Paganessi LA, Alikhan WA, Paganessi EA, Hughes F, Fung HC, Rich E, Seong CM, Christopherson KW 2nd.

Transfusion. 2013 Apr;53(4):878-87. doi: 10.1111/j.1537-2995.2012.03826.x. Epub 2012 Aug 6.

10.

Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment.

Cowan AJ, Seldin DC, Skinner M, Quillen K, Doros G, Tan J, O'Hara C, Finn KT, Sanchorawala V.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1935-8. doi: 10.1016/j.bbmt.2012.07.016. Epub 2012 Jul 27.

11.

Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma.

Ria R, Reale A, Solimando AG, Mangialardi G, Moschetta M, Gelao L, Iodice G, Vacca A.

Stem Cells Int. 2012;2012:607260. doi: 10.1155/2012/607260. Epub 2012 May 31.

12.

The effective use of plerixafor as a real-time rescue strategy for patients poorly mobilizing autologous CD34(+) cells.

Gopal AK, Karami M, Mayor J, Macebeo M, Linenberger M, Bensinger WI, Holmberg L.

J Clin Apher. 2012;27(2):81-7. doi: 10.1002/jca.21206. Epub 2012 Feb 2.

13.

Is there a role for 'modified VAD' in the treatment of multiple myeloma?

Agazzi A, Sammassimo S, Laszlo D, Liptrott S, Cascio R, Alietti A, Rabascio C, Mancuso P, Pruneri G, Martinelli G.

Ecancermedicalscience. 2009;3:136. doi: 10.3332/ecancer.2009.136. Epub 2009 Jun 4.

14.

Harvesting, processing and inventory management of peripheral blood stem cells.

Mijovic A, Pamphilon D.

Asian J Transfus Sci. 2007 Jan;1(1):16-23. doi: 10.4103/0973-6247.28068.

15.

Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.

Olivieri A, Marchetti M, Lemoli R, Tarella C, Iacone A, Lanza F, Rambaldi A, Bosi A; Italian Group for Stem Cell Transplantation.

Bone Marrow Transplant. 2012 Mar;47(3):342-51. doi: 10.1038/bmt.2011.82. Epub 2011 May 30.

16.

The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes.

Marquez-Curtis LA, Turner AR, Sridharan S, Ratajczak MZ, Janowska-Wieczorek A.

Stem Cell Rev. 2011 Sep;7(3):590-607. doi: 10.1007/s12015-010-9212-8. Review.

17.

Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.

Sinha S, Gastineau D, Micallef I, Hogan W, Ansell S, Buadi F, Dingli D, Dispenzieri A, Gertz M, Greiner C, Hayman S, Inwards D, Johnston P, Lacy M, Litzow M, Porrata L, Winters JL, Kumar S.

Bone Marrow Transplant. 2011 Jul;46(7):943-9. doi: 10.1038/bmt.2010.236. Epub 2010 Oct 11.

18.

Comparison of high-dose CY and growth factor with growth factor alone for mobilization of stem cells for transplantation in patients with multiple myeloma.

Gertz MA, Kumar SK, Lacy MQ, Dispenzieri A, Hayman SR, Buadi FK, Dingli D, Gastineau DA, Winters JL, Litzow MR.

Bone Marrow Transplant. 2009 Apr;43(8):619-25. doi: 10.1038/bmt.2008.369. Epub 2008 Nov 10.

19.

Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Pelus LM.

Curr Opin Hematol. 2008 Jul;15(4):285-92. doi: 10.1097/MOH.0b013e328302f43a. Review.

20.

Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.

Pelus LM, Fukuda S.

Leukemia. 2008 Mar;22(3):466-73. Epub 2007 Nov 1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk